ABBOTT LABORATORIES

ABT · Large cap · 0 articles

Financial highlights

Metric	FY 12/31/25	FY 12/31/24	FY 12/31/23	FY 12/31/22	FY 12/31/21
Income Statement
Revenue	$44.3B	$42.0B	$40.1B	$43.7B	$43.1B
Cost of revenue	$19.3B	$18.7B	$18.0B	$19.1B	$18.5B
Selling, general & administrative	$12.3B	$11.7B	$10.9B	$11.2B	$11.3B
Research and development	$2.9B	$2.8B	$2.7B	$2.9B	$2.7B
Operating income	$8.1B	$6.8B	$6.5B	$8.4B	$8.4B
Interest expense	$493.0M	$559.0M	$637.0M	$558.0M	$533.0M
Pretax income	$8.5B	$7.0B	$6.7B	$8.3B	$8.2B
Income tax expense	$1.9B	-$6.4B	$941.0M	$1.4B	$1.1B
Net income	$6.5B	$13.4B	$5.7B	$6.9B	$7.1B
Balance Sheet
Cash and equivalents	$8.5B	$7.6B	$6.9B	$9.9B	$9.8B
Current assets	$26.0B	$23.7B	$22.7B	$25.2B	$24.2B
Total assets	$86.7B	$81.4B	$73.2B	$74.4B	$75.2B
Current liabilities	$16.5B	$14.2B	$13.8B	$15.5B	$13.1B
Stockholders' equity	$52.1B	$47.7B	$38.6B	$36.7B	$35.8B
Cash Flow Statement
Cash from operations	$9.6B	$8.6B	$7.3B	$9.6B	$10.5B
Depreciation and amortization	$1.4B	$1.3B	$1.3B	$1.3B	$1.5B
Stock-based compensation	$664.0M	$673.0M	$644.0M	$685.0M	$640.0M
Capital expenditure	$2.2B	$2.2B	$2.2B	$1.8B	$1.9B
Free cash flow	$7.4B	$6.4B	$5.1B	$7.8B	$8.6B
Dividends paid	$4.1B	$3.8B	$3.6B	$3.3B	$3.2B
Share repurchases	$893.0M	$1.3B	$1.2B	$3.8B	$2.3B
Impairments	$0	$0	$0	$0	$0

Shares outstanding 1.7B · Free float 99.5%

Annual filing data through FY ended December 31, 2025; float as of July 7, 2026.